These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32910499)

  • 1. SARS-CoV-2 and myasthenia.
    Finsterer J; Scorza FA; Scorza CA; Fiorini AC
    J Med Virol; 2021 Jul; 93(7):4133-4135. PubMed ID: 32910499
    [No Abstract]   [Full Text] [Related]  

  • 2. Content of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis, and Eaton-Lambert syndrome.
    Lindstrom JM; Lambert EH
    Neurology; 1978 Feb; 28(2):130-8. PubMed ID: 202890
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunocompromised myasthenia gravis patient not infected with SARS-CoV-2 after close exposure - what is the risk of COVID-19?
    Rzepiński Ł; Wawrzyniak S; Maciejek Z
    Neurol Neurochir Pol; 2020; 54(5):481-482. PubMed ID: 33006133
    [No Abstract]   [Full Text] [Related]  

  • 4. The T-cell repertoire in myasthenia gravis involves multiple cholinergic receptor epitopes.
    Link H; Xu ZY; Melms A; Kalbacher H; Sun JB; Wang ZY; Fredrikson S; Olsson T
    Scand J Immunol; 1992 Sep; 36(3):405-14. PubMed ID: 1381518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MuSK Antibody-Associated Myasthenia Gravis With SARS-CoV-2 Infection: A Case Report.
    Muhammed L; Baheerathan A; Cao M; Leite MI; Viegas S
    Ann Intern Med; 2021 Jun; 174(6):872-873. PubMed ID: 33428437
    [No Abstract]   [Full Text] [Related]  

  • 6. Acquired rippling muscle disease associated with mild myasthenia gravis: a case report.
    van Schaik SM; Kwa VI; van der Kooi AJ
    J Neurol; 2009 Jul; 256(7):1187-8. PubMed ID: 19277764
    [No Abstract]   [Full Text] [Related]  

  • 7. Myasthenia gravis and recurrent falls in an elderly patient.
    Chua E; McLoughlin C; Sharma AK
    Age Ageing; 2000 Jan; 29(1):83-4. PubMed ID: 10690702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
    Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short review of progress in experimental myasthenia gravis, bearing on the pathogenesis of myasthenia gravis.
    Heilbronn E
    Prog Brain Res; 1979; 49():459-63. PubMed ID: 390612
    [No Abstract]   [Full Text] [Related]  

  • 10. Complement inhibition initiated recovery of a severe myasthenic crisis with COVID-19.
    Hofstadt-van Oy U; Stankovic S; Kelbel C; Oswald D; Larrosa-Lombardi S; Barchfeld T; Cleff U
    J Neurol; 2021 Sep; 268(9):3125-3128. PubMed ID: 33537898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands.
    Niks EH; Kuks JB; Verschuuren JJ
    J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):417-8. PubMed ID: 17056627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on COVID-19 in patients with myasthenia gravis.
    Galassi G; Marchioni A
    Muscle Nerve; 2020 Dec; 62(6):E85-E86. PubMed ID: 32929765
    [No Abstract]   [Full Text] [Related]  

  • 13. Electronic health record derived-impact of COVID-19 on myasthenia gravis.
    Roy B; Kovvuru S; Nalleballe K; Onteddu SR; Nowak RJ
    J Neurol Sci; 2021 Apr; 423():117362. PubMed ID: 33639420
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19-associated risks and effects in myasthenia gravis (CARE-MG).
    Muppidi S; Guptill JT; Jacob S; Li Y; Farrugia ME; Guidon AC; Tavee JO; Kaminski H; Howard JF; Cutter G; Wiendl H; Maas MB; Illa I; Mantegazza R; Murai H; Utsugisawa K; Nowak RJ;
    Lancet Neurol; 2020 Dec; 19(12):970-971. PubMed ID: 33212055
    [No Abstract]   [Full Text] [Related]  

  • 15. Myasthenia gravis: an autoimmune response against the acetylcholine receptor.
    Graus YM; De Baets MH
    Immunol Res; 1993; 12(1):78-100. PubMed ID: 7685805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 may unravel metabolic myopathy mistaken for myasthenia.
    Finsterer J; Maeztu C
    Rev Esp Geriatr Gerontol; 2021; 56(2):124-125. PubMed ID: 33610379
    [No Abstract]   [Full Text] [Related]  

  • 17. Increasing incidence of myasthenia gravis among elderly in British Columbia, Canada.
    Pakzad Z; Aziz T; Oger J
    Neurology; 2011 Apr; 76(17):1526-8. PubMed ID: 21519005
    [No Abstract]   [Full Text] [Related]  

  • 18. Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63.
    Saletti G; Gerlach T; Jansen JM; Molle A; Elbahesh H; Ludlow M; Li W; Bosch BJ; Osterhaus ADME; Rimmelzwaan GF
    Sci Rep; 2020 Dec; 10(1):21447. PubMed ID: 33293664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In myasthenia gravis cells from atrophic thymus secrete acetylcholine receptor antibodies.
    Katzberg HD; Aziz T; Oger J
    Neurology; 2001 Feb; 56(4):572-3. PubMed ID: 11222815
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation between myasthenia gravis-activities of daily living (MG-ADL) and quantitative myasthenia gravis (QMG) assessments of anti-acetylcholine receptor antibody-positive refractory generalized myasthenia gravis in the phase 3 regain study.
    Vissing J; O'Brien F; Wang JJ; Howard JF
    Muscle Nerve; 2018 Aug; 58(2):E21-E22. PubMed ID: 29684239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.